{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:51:11Z","timestamp":1790171471871,"version":"4.1.0"},"reference-count":51,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T00:00:00Z","timestamp":1677974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal of Australia"],"published-print":{"date-parts":[[2023,3,20]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Prison settings represent the highest concentration of prevalent hepatitis C cases in Australia due to the high rates of incarceration among people who inject drugs. Highly effective direct\u2010acting antiviral (DAA) therapies for hepatitis C virus (HCV) infection are available to people incarcerated in Australian prisons. However, multiple challenges to health care implementation in the prison sector present barriers to people in prison reliably accessing hepatitis C testing, treatment, and prevention measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main recommendations<\/jats:title><jats:p>This Consensus statement highlights important considerations for the management of hepatitis C in Australian prisons. High coverage testing, scale\u2010up of streamlined DAA treatment pathways, improved coverage of opioid agonist therapy, and implementation and evaluation of regulated provision of prison needle and syringe programs to reduce HCV infection and reinfection are needed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Changes in management as a result of this statement<\/jats:title><jats:p>The recommendations set current best practice standards in hepatitis C diagnosis, treatment and prevention in the Australian prison sector based on available evidence. Prison\u2010based health services should strive to simplify and improve efficiency in the provision of the hepatitis C care cascade, including strategies such as universal opt\u2010out testing, point\u2010of\u2010care testing, simplified assessment protocols, and earlier confirmation of cure. Optimising hepatitis C management in prisons is essential to prevent long term adverse outcomes for a marginalised population living with HCV. Scale\u2010up of testing and treatment in prisons will make a major contribution towards Australia's efforts to eliminate hepatitis C as a public health threat by 2030.<\/jats:p><\/jats:sec>","DOI":"10.5694\/mja2.51854","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T14:01:29Z","timestamp":1678024889000},"page":"231-237","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Consensus recommendations on the management of hepatitis C in Australia's prisons"],"prefix":"10.5694","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2067-4278","authenticated-orcid":false,"given":"Rebecca J","family":"Winter","sequence":"first","affiliation":[{"name":"Monash University  Melbourne VIC"},{"name":"Burnet Institute  Melbourne VIC"},{"name":"St Vincent's Hospital  Melbourne VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Sheehan","sequence":"additional","affiliation":[{"name":"Kirby Institute, University of New South Wales  Sydney NSW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Papaluca","sequence":"additional","affiliation":[{"name":"St Vincent's Hospital  Melbourne VIC"},{"name":"University of Melbourne  Melbourne VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme A","family":"Macdonald","sequence":"additional","affiliation":[{"name":"University of Queensland  Brisbane QLD"},{"name":"Princess Alexandra Hospital  Brisbane QLD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Rowland","sequence":"additional","affiliation":[{"name":"Department of Justice, Government of Western Australia  Perth WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Colman","sequence":"additional","affiliation":[{"name":"Royal Adelaide Hospital  Adelaide SA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stoove","sequence":"additional","affiliation":[{"name":"Monash University  Melbourne VIC"},{"name":"Burnet Institute  Melbourne VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-8887","authenticated-orcid":false,"given":"Andrew R","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Kirby Institute, University of New South Wales  Sydney NSW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J","family":"Thompson","sequence":"additional","affiliation":[{"name":"St Vincent's Hospital  Melbourne VIC"},{"name":"University of Melbourne  Melbourne VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,3,5]]},"reference":[{"key":"e_1_2_9_1_1","unstructured":"Australian Government Department of Health.Fifth National Hepatitis C Strategy 2018\u20132022.Canberra:Commonwealth of Australia 2018.https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2022\/06\/fifth\u2010national\u2010hepatitis\u2010c\u2010strategy\u20102018\u20102022.pdf(viewed Oct 2022)."},{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2011.tb03029.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207226"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50544"},{"key":"e_1_2_9_5_1","unstructured":"Australian Bureau of Statistics. Corrective Services Australia: national and state information about adult prisoners and community based corrections including legal status custody type Indigenous status sex [reference period: March June September and December quarters 2021].Canberra:ABS 2022.https:\/\/www.abs.gov.au\/statistics\/people\/crime\u2010and\u2010justice\/corrective\u2010services\u2010australia(viewed Jan 2023)."},{"key":"e_1_2_9_6_1","unstructured":"ButlerT SimpsonM.National Prison Entrants\u2019 Bloodborne Virus and Risk Behaviour Survey Report 2004 2007 2010 2013 and 2016.Sydney:Kirby Institute University of New South Wales 2017.https:\/\/kirby.unsw.edu.au\/sites\/default\/files\/kirby\/report\/JHP_National\u2010Prison\u2010Entrants\u2010Report\u20102004\u20102007\u20102010\u20102013\u20102016.pdf(viewed July 2022)."},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12701"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1685538"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.01.012"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245896"},{"key":"e_1_2_9_11_1","volume-title":"Australia's progress towards hepatitis C elimination: annual report 2022","author":"Burnet Institute","year":"2022"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00077-7"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0246-6"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit265"},{"key":"e_1_2_9_15_1","unstructured":"WinterRJ SheehanY PapalucaTJ et al;National Prisons Hepatitis Network. Consensus statement on the management of hepatitis C in Australia's prisons \u2014 May 2022.National Prisons Hepatitis Network 2022.www.nphn.net.au\/_files\/ugd\/2e8dca_2ef131909bf74cedbfb40475e6da3110.pdf(viewed Jan 2023)."},{"key":"e_1_2_9_16_1","unstructured":"Hepatitis C Virus Infection Consensus Statement Working Group.Australian recommendations for the management of hepatitis C virus infection: a consensus statement [June 2020].Melbourne:Gastroenterological Society of Australia 2020.https:\/\/www.hepcguidelines.org.au\/(viewed Oct 2022)."},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13600"},{"key":"e_1_2_9_18_1","first-page":"S294","article-title":"Concordance of SVR 4\u201012\u201024 timepoints in an era of reduced sustained virologic response (SVR) determination","volume":"75","author":"Sulkowski M","year":"2021","journal-title":"J Hepatol"},{"key":"e_1_2_9_19_1","unstructured":"Pharmaceutical Benefits Scheme.Prescribing medicines \u2014 information for PBS prescribers: Regulation 49[website].https:\/\/www.pbs.gov.au\/info\/healthpro\/explanatory\u2010notes\/section1\/Section_1_2_Explanatory_Notes#Regulation\u201049(viewed Jan 2023)."},{"key":"e_1_2_9_20_1","article-title":"What is GRADE [website]","author":"Siemieniuk R","year":"2022","journal-title":"BMJ Best Practice"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/1753-6405.12578"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50140"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0617"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckv133"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa612"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242101"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2000.00021.x"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/SGA.0000000000000458"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01694.x"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.04.003"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2021.1921737"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac350"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.11.005"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32002"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03676.x"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02826.x"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir196"},{"key":"e_1_2_9_38_1","unstructured":"World Health Organization.WHO UNODC UNAIDS Technical Guide for countries to set targets for universal access to HIV prevention treatment and care for injecting drug users \u2014 2012 revision.Geneva:WHO 2022.https:\/\/www.who.int\/publications\/i\/item\/978924150437(viewed July 2022)."},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14012"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxx019"},{"key":"e_1_2_9_41_1","unstructured":"DolanK BrentariC StevensA KhoeiEM.Prisons and drugs: a global review of incarceration drug use and drug services.London:Beckley Foundation 2007.https:\/\/kar.kent.ac.uk\/13324\/(viewed July 2022)."},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2003.08.001"},{"key":"e_1_2_9_43_1","unstructured":"Hepatitis NSW.Use of Fincol in NSW prisons: preventing hep C transmission [website].Hepatitis NSW 2019.https:\/\/www.hep.org.au\/blog\/use\u2010of\u2010fincol\u2010in\u2010nsw\u2010prisons\/(viewed Nov 2020)."},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30075-9"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14830"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-80"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.04.024"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0269-z"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1584-x"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12987"},{"key":"e_1_2_9_51_1","unstructured":"Centre for Social Research in Health.Stigma Indicators Monitoring Project: people who inject drugs.Sydney:University of New South Wales 2018.https:\/\/www.arts.unsw.edu.au\/centre\u2010social\u2010research\u2010health\/our\u2010projects\/stigma\u2010indicators\u2010monitoring\u2010project(viewed July 2022)."}],"container-title":["Medical Journal of Australia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.5694\/mja2.51854","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.5694\/mja2.51854","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.5694\/mja2.51854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T07:55:59Z","timestamp":1710316559000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.5694\/mja2.51854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,3,20]]}},"alternative-id":["10.5694\/mja2.51854"],"URL":"https:\/\/doi.org\/10.5694\/mja2.51854","archive":["Portico"],"relation":{},"ISSN":["0025-729X","1326-5377"],"issn-type":[{"value":"0025-729X","type":"print"},{"value":"1326-5377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,5]]},"assertion":[{"value":"2022-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}